ТОО "НАЦИОНАЛЬНЫЙ ЦЕНТР БИОТЕХНОЛОГИИ"
This is a company preview
Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.
Risks
1/18Комитет государственных доходов · Государственные закупки РК · АО ФНБ «Самрук-Казына» · АОО «НИШ»Комитет государственных доходов · data as of 10.11.2026
This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.
Procurement signals
Court cases
Arrests & encumbrances
Enforcement proceedings
Certificates
Licenses and permits
Summary
Министерство юстиции РКActivities
1ОКЭДИная профессиональная, научная и техническая деятельность, не включенная в другие группировки
Contacts
Change history
Financial statements
PremiumPublic contracts
What it sells and where
Samruk-Kazyna procurement
Tender bids
Procurement as a customer
Assets
Bank accounts
Leadership
1- НЖ
Нургалиев Жайсанбай Азербаевич
Director
Founders
Accreditations
Employees
Affiliated companies
PremiumDirector's involvement in other legal entities
Branches
Company networks
PremiumSimilar companies
Media mentions
Company summary
Liquidated legal entity ТОО "НАЦИОНАЛЬНЫЙ ЦЕНТР БИОТЕХНОЛОГИИ" (BIN 180640033012), West Kazakhstan Region. Registered in 2018. Main activity: other professional activities. Small enterprise, headcount: up to 5 employees. Automated screening found 1 risk indicator for «НАЦИОНАЛЬНЫЙ ЦЕНТР БИОТЕХНОЛОГИИ»: liquidated according to the tax authority. Structure on record: 1 founder. The registry names Нургалиев Жайсанбай Азербаевич as director. Per the registry as of June 11, 2026.
Data sources and disclaimer
Sources: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is collected automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the fact. This is reference information and does not replace an official extract. Methodology: SafeDeal editorial policy.